136 related articles for article (PubMed ID: 620413)
1. Restoration of growth control in malignantly transformed mouse fibroblasts grown in a chemically defined medium.
Tomei LD; Bertram JS
Cancer Res; 1978 Feb; 38(2):444-51. PubMed ID: 620413
[TBL] [Abstract][Full Text] [Related]
2. Differences in anchorage-dependent growth and tumorigenicities between transformed C3H/10T 1/2 cells with morphologies that are or are not reverted to a normal phenotype by ascorbic acid.
Benedict WF; Wheatley WL; Jones PA
Cancer Res; 1982 Mar; 42(3):1041-5. PubMed ID: 7059969
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cellular interactions between C3H/10T1/2 cells and their transformed counterparts by phosphodiesterase inhibitors.
Bertram JS
Cancer Res; 1979 Sep; 39(9):3502-8. PubMed ID: 89899
[TBL] [Abstract][Full Text] [Related]
4. Effects of serum concentration on the expression of carcinogen-induced transformation in the C3H/10T1/2 CL8 cell line.
Bertram JS
Cancer Res; 1977 Feb; 37(2):514-23. PubMed ID: 401680
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
[TBL] [Abstract][Full Text] [Related]
6. Disposition of endogenous homocysteine by mouse fibroblast C3H/10T1/2 Cl 8 and the chemically transformed C3H/10T1/2 MCA Cl 16 cells following methotrexate exposure.
Ueland PM; Refsum H; Male R; Lillehaug JR
J Natl Cancer Inst; 1986 Jul; 77(1):283-9. PubMed ID: 3459921
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of human diploid fibroblasts transformed in vitro by chemical carcinogens.
Zimmerman RJ; Little JB
Cancer Res; 1983 May; 43(5):2183-9. PubMed ID: 6831442
[TBL] [Abstract][Full Text] [Related]
8. Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cells.
Smith GJ; Bell WN; Grisham JW
Cancer Res; 1993 Feb; 53(3):500-8. PubMed ID: 8425183
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of chemically induced morphological transformation and reversion of the transformed phenotype of ascorbic acid in C3H/10T 1/2 cells.
Benedict WF; Wheatley WL; Jones PA
Cancer Res; 1980 Aug; 40(8 Pt 1):2796-801. PubMed ID: 6248214
[No Abstract] [Full Text] [Related]
10. Glutaraldehyde-fixed transformed and non-transformed cells induce contact-dependent inhibition of growth in non-transformed C3H/10T1/2 mouse fibroblasts, but not in 3-methylcholanthrene-transformed cells.
Oesch F; Janik-Schmitt B; Ludewig G; Glatt H; Wieser RJ
Eur J Cell Biol; 1987 Jun; 43(3):403-7. PubMed ID: 3113956
[TBL] [Abstract][Full Text] [Related]
11. [The cultivation features, growth characteristics and oncogenicity of "serum-free" populations of transformed fibroblasts].
Pleskach VA; Kozhukharova IV; Artsybasheva IV; Goĭlo TA; Tarunina MV; Filatova NA
Tsitologiia; 1994; 36(8):806-15. PubMed ID: 7701611
[TBL] [Abstract][Full Text] [Related]
12. Neoplasms produced from C3H/10T 1/2 cells attached to plastic plates; saturation density, anchorage dependence and serum requirement of in vitro lines correlated with growth aggressiveness in vivo.
Paranjpe M; del Ande Eaton S; Boone CW
J Cell Physiol; 1978 Jul; 96(1):63-71. PubMed ID: 659520
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
Robinson RA; Branum EL; Volkenant ME; Moses HL
Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
[TBL] [Abstract][Full Text] [Related]
14. Cell surface features associated with differentiation-induction of methylcholanthrene-transformed AKR-2B fibroblasts by N,N-dimethylformamide.
Marks ME; Ziober BL; Brattain MG
Cancer Res; 1985 Mar; 45(3):1276-84. PubMed ID: 3855694
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the glucose-regulated gene encoding the Mr 78,000 glucose-regulated protein in chemically and radiation-transformed C3H 10T1/2 mouse embryo cells.
Patierno SR; Tuscano JM; Kim KS; Landolph JR; Lee AS
Cancer Res; 1987 Dec; 47(23):6220-4. PubMed ID: 2445468
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the malignant potential of 10T 1/2 cells and transformants with their survival responses to hyperthermia and to amphotericin B1.
Hahn GM
Cancer Res; 1980 Oct; 40(10):3763-7. PubMed ID: 7438060
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of thymidine uptake and cell proliferation in mouse embryo fibroblasts by conditioned medium from mammary cells in culture.
Howard EF; Scott DF; Bennett CE
Cancer Res; 1976 Dec; 36(12):4543-51. PubMed ID: 1000499
[TBL] [Abstract][Full Text] [Related]
18. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype.
Gapuzan ME; Yufit PV; Gilmore TD
Oncogene; 2002 Apr; 21(16):2484-92. PubMed ID: 11971183
[TBL] [Abstract][Full Text] [Related]
19. Growth factors, growth factor receptors, and cell cycle control mechanisms in chemically transformed cells.
Moses HL; Robinson RA
Fed Proc; 1982 Nov; 41(13):3008-11. PubMed ID: 6292004
[TBL] [Abstract][Full Text] [Related]
20. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.
Dowdy SF; Weissman BE; Stanbridge EJ
J Cell Physiol; 1991 May; 147(2):248-55. PubMed ID: 1645741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
